{"id":702182,"date":"2024-06-11T15:56:01","date_gmt":"2024-06-11T15:56:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=702182"},"modified":"2024-06-11T15:56:01","modified_gmt":"2024-06-11T15:56:01","slug":"spinal-implants-market-worth-143-billion-marketsandmarkets","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/spinal-implants-market-worth-143-billion-marketsandmarkets_702182.html","title":{"rendered":"Spinal Implants Market Worth $14.3 Billion | MarketsandMarkets\u2122"},"content":{"rendered":"
\n
\"Spinal<\/a><\/div>\n
\n
prominent players in the spinal implants market are Medtronic (Ireland), Depuy Synthes- Johnson & Johnson (US), NuVasive (US), Spineart (Switzerland), RTI Surgical (Germany), Zimmer Biomet Holdings (US), Globus Medical Inc. (US), Abbott Laboratories (US) and Boston Scientific Corporation (US), Stryker Corporation (US), among others.<\/div>\n<\/div>\n<\/div>\n
Browse 359 market data Tables and 45 Figures spread through 335 Pages and in-depth TOC on “Spinal Implants Market by Product (Devices (Thoracic, Cervical, Interbody Fusion, Spinal Non-Fusion), Biologics, Stimulators), Application (VCF, Spinal Decompression, Fusion, Non-Fusion), Surgery (Open, MIS), Region & Customer Unmet Need Forecast to 2028<\/div>\n

Spinal Implants Market<\/a><\/strong> in terms of revenue was estimated to be worth $11.2 billion in 2023 and is poised to reach $14.3 billion by 2028, growing at a CAGR of 5.0% from 2023 to 2028 according to a new report by MarketsandMarkets™. The expansion of the spinal implants market is propelled by several synergistic factors, including increasing demand for minimally invasive surgical procedures, escalating spinal disorder prevalence, rising geriatric patient population, growing public-private investments to support for the clinical research and the presence of key market players in developing regions.<\/p>\n

Download an Illustrative overview: https:\/\/www.marketsandmarkets.com\/pdfdownloadNew.asp?id=712<\/a><\/strong><\/p>\n

Non-Fusion Devices segment to register a significant growth rate over the forecast period of 2022-2028.<\/strong><\/p>\n

Based on the product, the spinal implants market is segmented into Thoracic Fusion and lumbar Fusion Devices, Cervical Fusion Devices, Spine Biologics, Spinal Decompression Devices, Non-Fusion Devices, Vertebral Compression Fracture Treatment Devices, and Spine Bone Stimulators. The surge in spinal disorder and non-fusion procedures often involve less disruption to surrounding tissues and may result in shorter recovery times. Furthermore, The adoption of non-fusion devices in spinal implants reflects a shift toward more patient-centered, minimally invasive approaches that aim to address spinal conditions while preserving motion and reducing the potential for complications associated with fusion surgeries are significant contributors to this segment’s substantial market share.<\/p>\n

Open Surgeries segment accounted for the significant share of the spinal implants market in 2022-2028.<\/strong><\/p>\n

Based on the type of surgery, Open Surgeries is the preferred application for surgeons in spine surgical procedures for complex spinal deformities, such as severe scoliosis or advanced kyphosis. The direct visualization provided by open procedures allows surgeons to address intricate anatomical abnormalities more effectively. Additionally, In trauma cases, open procedures are often used when the surgeon needs quick access to treat fractures, dislocations, and other severe injuries., is anticipated to bolster the segment’s growth.<\/p>\n

North America to account for a significant market share in the spinal implants market in 2022.<\/strong><\/p>\n

Based on region, The spinal implants market is categorized into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa, with North America dominating the market share in 2022. This dominance in North America is propelled by factors such as a growing elderly population, a high incidence of spinal disorder, a rise in demand for minimally invasive surgical procedures, and the presence of well-established players with robust spinal implants portfolios. Furthermore, growing research and funding initiatives from public and private organizations are expected to further boost the spinal implants market in North America.<\/p>\n

Request Sample Pages: <\/strong>https:\/\/www.marketsandmarkets.com\/requestsampleNew.asp?id=712<\/a><\/strong><\/p>\n

Spinal Implants Market<\/strong> Dynamics:<\/strong><\/p>\n

Drivers:<\/strong><\/p>\n

    \n
  1. Increase in prevalence of spinal disorder<\/li>\n<\/ol>\n

    Restraint:<\/strong><\/p>\n

      \n
    1. Issues related to high cost of procedures<\/li>\n<\/ol>\n

      Opportunities:<\/strong><\/p>\n

        \n
      1. Emerging markets offering growth opportunities<\/li>\n<\/ol>\n

        Challenge:<\/strong><\/p>\n

          \n
        1. Lack of adequate physicians and limited awareness<\/li>\n<\/ol>\n

          Key Market Players of <\/strong>Spinal Implants Industry<\/strong>:<\/strong><\/p>\n

          As of 2022, prominent players in the spinal implants market are Medtronic (Ireland), Depuy Synthes- Johnson & Johnson (US), NuVasive (US), Spineart (Switzerland), RTI Surgical (Germany), Zimmer Biomet Holdings (US), Globus Medical Inc. (US), Abbott Laboratories (US) and Boston Scientific Corporation (US), Stryker Corporation (US), among others.<\/p>\n

          A breakdown of the primary participants referred to for this report is provided below:<\/strong><\/p>\n